Exact Mass: 458.3217

Exact Mass Matches: 458.3217

Found 25 metabolites which its exact mass value is equals to given mass value 458.3217, within given mass tolerance error 0.0002 dalton. Try search metabolite list with more accurate mass tolerance error 4.0E-5 dalton.

Ala Ile Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-aminopropanamido]-3-methylpentanamido]hexanamido]hexanoic acid

C21H42N6O5 (458.3217)

Ala Lys Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-3-methylpentanamido]hexanoic acid

C21H42N6O5 (458.3217)

Ala Lys Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]hexanamido]-3-methylpentanoic acid

C21H42N6O5 (458.3217)

Ala Lys Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]hexanamido]-4-methylpentanoic acid

C21H42N6O5 (458.3217)

Ala Lys Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-aminopropanamido]hexanamido]-4-methylpentanamido]hexanoic acid

C21H42N6O5 (458.3217)

Ala Leu Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-aminopropanamido]-4-methylpentanamido]hexanamido]hexanoic acid

C21H42N6O5 (458.3217)

Ile Ala Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-amino-3-methylpentanamido]propanamido]hexanamido]hexanoic acid

C21H42N6O5 (458.3217)

Ile Lys Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]propanamido]hexanoic acid

C21H42N6O5 (458.3217)

Ile Lys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S,3S)-2-amino-3-methylpentanamido]hexanamido]hexanamido]propanoic acid

C21H42N6O5 (458.3217)

Lys Ala Ile Lys

(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-3-methylpentanamido]hexanoic acid

C21H42N6O5 (458.3217)

Lys Ala Lys Ile

(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]hexanamido]-3-methylpentanoic acid

C21H42N6O5 (458.3217)

Lys Ala Lys Leu

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]hexanamido]-4-methylpentanoic acid

C21H42N6O5 (458.3217)

Lys Ala Leu Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]propanamido]-4-methylpentanamido]hexanoic acid

C21H42N6O5 (458.3217)

Lys Ile Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]propanamido]hexanoic acid

C21H42N6O5 (458.3217)

Lys Ile Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S,3S)-2-[(2S)-2,6-diaminohexanamido]-3-methylpentanamido]hexanamido]propanoic acid

C21H42N6O5 (458.3217)

Lys Lys Ala Ile

(2S,3S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]propanamido]-3-methylpentanoic acid

C21H42N6O5 (458.3217)

Lys Lys Ala Leu

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]propanamido]-4-methylpentanoic acid

C21H42N6O5 (458.3217)

Lys Lys Ile Ala

(2S)-2-[(2S,3S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-3-methylpentanamido]propanoic acid

C21H42N6O5 (458.3217)

Lys Lys Leu Ala

(2S)-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2,6-diaminohexanamido]hexanamido]-4-methylpentanamido]propanoic acid

C21H42N6O5 (458.3217)

Lys Leu Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]propanamido]hexanoic acid

C21H42N6O5 (458.3217)

Lys Leu Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-4-methylpentanamido]hexanamido]propanoic acid

C21H42N6O5 (458.3217)

Leu Ala Lys Lys

(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-[(2S)-2-amino-4-methylpentanamido]propanamido]hexanamido]hexanoic acid

C21H42N6O5 (458.3217)

Leu Lys Ala Lys

(2S)-6-amino-2-[(2S)-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]propanamido]hexanoic acid

C21H42N6O5 (458.3217)

Leu Lys Lys Ala

(2S)-2-[(2S)-6-amino-2-[(2S)-6-amino-2-[(2S)-2-amino-4-methylpentanamido]hexanamido]hexanamido]propanoic acid

C21H42N6O5 (458.3217)

LSKL, Inhibitor of Thrombospondin (TSP-1)

C21H42N6O5 (458.3217)

LSKL, Inhibitor of Thrombospondin (TSP-1) is a latency-associated protein (LAP)-TGFβ derived tetrapeptide and a competitive TGF-β1 antagonist. LSKL, Inhibitor of Thrombospondin (TSP-1) inhibits the binding of TSP-1 to LAP and alleviates renal interstitial fibrosis and hepatic fibrosis. LSKL, Inhibitor of Thrombospondin (TSP-1) suppresses subarachnoid fibrosis via inhibition of TSP-1-mediated TGF-β1 activity, prevents the development of chronic hydrocephalus and improves long-term neurocognitive defects following subarachnoid hemorrhage (SAH). LSKL, Inhibitor of Thrombospondin (TSP-1) can readily crosse the blood-brain barrier[1][2].